Related references
Note: Only part of the references are listed.A Phase I Study of the Chinese Herbal Medicine PHY906 as a Modulator of Irinotecan-based Chemotherapy in Patients with Advanced Colorectal Cancer
Shivaani Kummar et al.
CLINICAL COLORECTAL CANCER (2011)
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
Uwe Pelzer et al.
EUROPEAN JOURNAL OF CANCER (2011)
Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS)
Wei Zhang et al.
JOURNAL OF CHROMATOGRAPHY A (2010)
Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies
M. Wasif Saif et al.
PHYTOMEDICINE (2010)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Interleukin-6 and epithelial tumours: new convincing arguments in favour of the use of IL-6 targeted therapies
Angelique Gougelet et al.
M S-MEDECINE SCIENCES (2008)
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer
Stefan Boeck et al.
ONCOLOGY (2007)
Edmonton symptom assessment scale: Italian validation in two palliative care settings
C Moro et al.
SUPPORTIVE CARE IN CANCER (2006)
Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: Expression analysis of genes related to outcome
MW Saif et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology
E Morgan et al.
CLINICAL IMMUNOLOGY (2004)
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer
W Scheithauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer
TH Cartwright et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
